Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2008
10/09/2008WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
10/09/2008WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
10/09/2008WO2008120708A1 Engraftment enhancer or proliferation enhancer in tissue plantation
10/09/2008WO2008120661A1 Novel fused pyrrole derivative
10/09/2008WO2008120655A1 Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type i
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008120472A1 Prophylactic and/or therapeutic agent for hyperlipemia
10/09/2008WO2008120214A2 Compositions containing phosphatidylserine in treating diabetes associated conditions
10/09/2008WO2008120000A1 Therapeutic agents
10/09/2008WO2008119999A1 Therapeutic agents
10/09/2008WO2008119657A1 Imidazolidinone derivatives
10/09/2008WO2008119571A2 Nucleic acid myostatin antagonist aptamers obtained by (mirror- image) selex
10/09/2008WO2008119248A1 Photochemical reaction preparative method of four-membered ring compounds
10/09/2008WO2008119238A1 Substituted five membered heterocycle compounds, preparation method and medical use thereof
10/09/2008WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
10/09/2008WO2008119163A1 Multi-nutrient milk fortifier
10/09/2008WO2008119110A1 Treatment of obesity
10/09/2008WO2008100627A3 The secreted protein ccdc80 regulates adipocyte differentiation
10/09/2008WO2008089008A3 Tetrahydrobiopterin prodrugs
10/09/2008WO2008071790A3 Novel compositions and uses thereof
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/09/2008WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression
10/09/2008US20080249177 Selective beta 3-adrenoceptor stimulants; obesity, diabetes mellitus, hyperlipidemia, pollakiuria, urinary incontinence, intestinal hypermotility; e.g. 4'-{2-[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl ethylamino]ethoxy}-2,3',5'-trimethylbiphenyl-4-carboxylic acid
10/09/2008US20080249171 Administering diacylglycerols to accumulate fatty acids in the small intestine to suppress biosynthesis of triacylglycerols; antidiabetic agents; insulin resistance; lower blood remnant/leptin level, enhancement of beta -oxidation and uncoupling protein (UCP) expression to promote energy consumption
10/09/2008US20080249169 Ameliorating the effects of a metabolic disorder by administering a magnesium-containing compound effective to increase a physiological concentration of magnesium by at least about 10%; magnesium threoate; neutraceuticals; bioavailabilty; antidiabetic agents; accurate analysis; nervous system disorders
10/09/2008US20080249166 Inhibiting hepatic fatty acid and sterol synthesis; use with statins; compounds such as cyclopropyl or cyclobutyl-functional hydroxy-functional alpha,gamma-alkanediacids
10/09/2008US20080249159 Ingesting daily a compound of tetrahydrolipstatin (Orlistat) for a period of at least two years to prevent weight regain; long-term therapy so as to permanently atrophy the endocrine cells which would otherwise generate more ghrelin; appetite reduction
10/09/2008US20080249156 Combinations of statins and anti-obesity agent and glitazones
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249137 e.g. {3-butoxy-5-[4-(4-trifluoromethoxy-phenoxy)-benzenesulfonyl]-phenyl}-acetic acid; peroxisome proliferator activated receptor modulator; antidiabetic agent; obesity, hyperlipidemia, dyslipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema
10/09/2008US20080249130 Oral dosage forms; antiproliferatives, anticholesterol agents; lipid metabolic disorders; myocardial infarction, stroke, restenosis, atherosclerosis
10/09/2008US20080249128 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
10/09/2008US20080249126 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals
10/09/2008US20080249115 small molecule, non-peptide, modulators (e.g., antagonists or agonists) of peptide hormones; treating low blood pressure or an eating disorder
10/09/2008US20080249114 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
10/09/2008US20080249100 N-[2-(2-{[(3,4-dichlorophenyl)methyl]amino}-7-oxo-8-hydropteridin-8-yl)ethyl]carboxamides; antidiabetic, anticholesterol, anticarcinogenic, antiischemic, hypotensive agents; obesity, stroke
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080249092 3-(phenylsulfonyl)-N-(tetrahydro-2H-pyran-4-ylmethyl)-8-quinolinamine; selectively modulating the cannabinoid 2 receptor; treatment of CNS disorders
10/09/2008US20080249089 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008US20080249017 Pharmaceutical formulations of ghrh molecules
10/09/2008US20080249015 Prophylaxis of influenza A infections; hypoglycemic agents; obesity; bulimia nervosa
10/09/2008US20080249011 Use of Mgc4504
10/09/2008US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions
10/09/2008US20080249007 Lysine residue of analog acylated with a diacid; substituted for an amino acid residue in [N-epsilon(17-carboxyheptadecanoic acid)20 exendin-4(1-39)-amide; hyperglycemia, type 2 diabetes, impaired glucose tolerance, type 1 diabetes, obesity, hypertension, syndrome X, dyslipidemia, cognitive disorders
10/09/2008US20080248999 Amylin formulations
10/09/2008US20080248995 Contact candidate compound with transfected expression vector containing heterologous gene linked to PPAR promoter and expression vector encoding FOXO1 protein; compare level of expression with absence of candidate to identify promoter
10/09/2008US20080248553 Recombinant food-grade microorganism for use as bioreactor in production of monoglutamyl folate
10/09/2008US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1
10/09/2008US20080248115 Combinations of statins and anti-obesity agent
10/09/2008US20080248101 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
10/09/2008US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide
10/09/2008US20080248055 Using glutamate decarboxylase therapeutic for treatment and prevention of pancreatic disorders
10/09/2008US20080248035 Pyrrole derivatives, dyslipidemic agents (cholesteryl ester transfer protein inhibitors), antiobesity agents (serontonin receptor inhibitors), antihyperglycemic agents (insulin sensitizing agents/PPAR agonists), anti-inflammatory agents
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248010 Protein kinase for use as tool in identifying modulators for treatment of diabetes
10/09/2008US20080248005 Isolation and Cultivation of Stem/Progenitor Cells From the Amniotic Membrane of Umbilical Cord and Uses of Cells Differentiated Therefrom
10/09/2008US20080247994 DNA vaccine
10/09/2008US20080247962 Pharmaceutical Compositions Comprising Higher Primary Aliphatic Alcohols and Hmg Coa Reductase Inhibitor and Process of Preparation Thereof
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008DE102007017433A1 Identifying substances suitable for treating a glucose metabolism disorder comprises determining if a test substance inhibits the activity or expression of FYVE finger-containing phosphatidylinositol kinase
10/09/2008CA2800324A1 Zilpaterol and salts thereof for use in increasing the rate of weight gain, improved feed efficiency and/or increasing carcass leanness in a bovine
10/09/2008CA2701638A1 Pharmaceutical calcimimetics
10/09/2008CA2682736A1 Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682715A1 New imidazo[4,5-b]pyridine-7-carboxamides 704
10/09/2008CA2682377A1 Heteroaryl derivatives
10/09/2008CA2682375A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
10/09/2008CA2682374A1 Medicinal composition, food or drink having effect of enhancing sympathetic nervous activity
10/09/2008CA2682202A1 Benzylic glycoside derivatives and methods of use
10/09/2008CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants
10/09/2008CA2681935A1 Treatment of obesity
10/09/2008CA2680407A1 Prophylactic and/or therapeutic agent for hyperlipidemia
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same
10/08/2008EP1978016A1 Asymmetric reduction method
10/08/2008EP1977750A1 Use of thioproline in body weight reduction treatments
10/08/2008EP1977741A2 Use of renin inhibitors in therapy
10/08/2008EP1977738A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation
10/08/2008EP1976859A1 CRYSTALLINE FORM OF 1´-(1-METHYLETHYL)- 4´-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5´-METHYL-1H-PYRAZOL-3´-O-beta-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976396A2 Composition comprising polyunsaturated fatty acids for improving membrane composition
10/08/2008EP1976395A2 Composition comprising polyunsaturated fatty acids for improving membrane composition
10/08/2008EP1646390B1 A1 adenosine receptor antagonists
10/08/2008EP1641799B8 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1487469B1 Co-beadlet of dha and rosemary
10/08/2008EP1476128B1 Lipase inhibiting composition
10/08/2008EP1465521A4 System and method for the pretreatment of the endplates of an intervertebral disc
10/08/2008EP1392323B1 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/08/2008EP1137762B1 Treatment of pompe's disease
10/08/2008EP1044015B1 Formulations for amylin agonist peptides with insulin
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN101282992A Anti-myostatin antibodies
10/08/2008CN101282977A Xanthine derivatives as selective hm74a agonists
10/08/2008CN101282976A Xanthine derivatives as selective HM74A agonists
10/08/2008CN101282974A Benzimidazole derivatives as SIRTUIN modulators
1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 1298